Cambridge Isotope Laboratories, Inc. (CIL) is a leading global company in the highly technical and rapidly growing fields of scientific and high technology markets. With over 40 years of consistent growth, CIL serves a diverse customer base that includes academia, pharmaceutical, medical diagnostics, and semiconductor industries, fostering collaborations with Nobel laureates and industry-leading scientists. As a subsidiary of the Otsuka Pharmaceutical Group, CIL partners with top instrument manufacturers and pioneering research groups to drive market growth and product development.